Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Furmonertinib
Trade Name
Synonyms AST2818|AST2818|Alflutinib
Drug Descriptions

Furmonertinib (alflutinib) is a third-generation EGFR inhibitor that targets both EGFR activating mutations and T790M, potentially leading to tumor growth inhibition (PMID: 33780662, PMID: 35662408).

DrugClasses EGFR Inhibitor 3rd gen 26
CAS Registry Number 1869057-83-9
NCIT ID C180535


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Anlotinib + Furmonertinib Anlotinib Furmonertinib 0 0
Crizotinib + Furmonertinib Crizotinib Furmonertinib 0 0
Dabrafenib + Furmonertinib + Trametinib Dabrafenib Furmonertinib Trametinib 0 0
Furmonertinib Furmonertinib 0 2
Furmonertinib + Methotrexate Furmonertinib Methotrexate 0 0
Furmonertinib + Pemetrexed Disodium Furmonertinib Pemetrexed Disodium 0 0
Furmonertinib + Savolitinib Furmonertinib Savolitinib 0 0

Additional content available in CKB BOOST